101 related articles for article (PubMed ID: 4355509)
21. Anti-HIV agents. III. Synthesis and in vitro anti-HIV activity of novel 1H,3H-thiazolo[3,4-a]imidazo[4,5-b]pyridines.
Chimirri A; Grasso S; Montforte AM; Monforte P; Zappalà M
Farmaco; 1994 May; 49(5):345-8. PubMed ID: 8080617
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of novel substituted 2-phenylpyrazolopyridines with potent activity against herpesviruses.
Gudmundsson KS; Johns BA; Wang Z; Turner EM; Allen SH; Freeman GA; Boyd FL; Sexton CJ; Selleseth DW; Moniri KR; Creech KL
Bioorg Med Chem; 2005 Sep; 13(18):5346-61. PubMed ID: 16039862
[TBL] [Abstract][Full Text] [Related]
23. Pyrazolo[1,5-a]pyridine antiherpetics: effects of the C3 substituent on antiviral activity.
Johns BA; Gudmundsson KS; Allen SH
Bioorg Med Chem Lett; 2007 May; 17(10):2858-62. PubMed ID: 17350256
[TBL] [Abstract][Full Text] [Related]
24. Antiviral compounds. IV. Synthesis and anti-influenza virus activity of amidinohydrazones.
Nishimura T; Yamazaki C; Toku H; Yoshii S; Hasegawa K
Chem Pharm Bull (Tokyo); 1974 Oct; 22(10):2444-7. PubMed ID: 4468091
[No Abstract] [Full Text] [Related]
25. Synthesis and evaluation of novel chloropyridazine derivatives as potent human rhinovirus (HRV) capsid-binding inhibitors.
Fan SY; Zheng ZB; Mi CL; Zhou XB; Yan H; Gong ZH; Li S
Bioorg Med Chem; 2009 Jan; 17(2):621-4. PubMed ID: 19091578
[TBL] [Abstract][Full Text] [Related]
26. Potent nonclassical nucleoside antiviral drugs based on the N,N-diarylformamidine concept.
Anastasi C; Hantz O; De Clercq E; Pannecouque C; Clayette P; Dereuddre-Bosquet N; Dormont D; Gondois-Rey F; Hirsch I; Kraus JL
J Med Chem; 2004 Feb; 47(5):1183-92. PubMed ID: 14971898
[TBL] [Abstract][Full Text] [Related]
27. Antiviral compounds. VI. Synthesis and anti-influenza virus activity of alkoxybenzalacetone amidinohydrazones.
Nishimura T; Yoshii S; Toku H; Hasegawa K; Nagaki D
Kitasato Arch Exp Med; 1975 Mar; 48(1):23-30. PubMed ID: 1195576
[No Abstract] [Full Text] [Related]
28. Synthesis and antiviral activity of 4'-hydroxy-5,6,7,8-tetramethoxyflavone.
Burnham WS; Sidwell RW; Tolman RL; Stout MG
J Med Chem; 1972 Oct; 15(10):1075-6. PubMed ID: 4341748
[No Abstract] [Full Text] [Related]
29. Synthesis and anti-rhinovirus activity of 2-styrylchromones.
Desideri N; Conti C; Mastromarino P; Mastropaolo F
Antivir Chem Chemother; 2000 Nov; 11(6):373-81. PubMed ID: 11227995
[TBL] [Abstract][Full Text] [Related]
30. Antiviral compounds. V. Synthesis and anti-influenza virus activity of amidinohydrazones of aliphatic monocarbonyl compounds.
Toku H; Nishimura T; Hasegawa K; Nagaki D
Kitasato Arch Exp Med; 1975 Mar; 48(1):19-22. PubMed ID: 1195575
[No Abstract] [Full Text] [Related]
31. [Synthesis and antiviral effects of adamantan derivatives].
May G; Peteri D
Arzneimittelforschung; 1973 May; 23(5):718-21. PubMed ID: 4351043
[No Abstract] [Full Text] [Related]
32. Synthesis and antifungal activity of some amidrazone derivatives.
Vio L; Mamolo MG; Ronsisvalle G; Oliveri S; Grego AM
Farmaco; 1989 Sep; 44(9):819-29. PubMed ID: 2690844
[TBL] [Abstract][Full Text] [Related]
33. [Synthesis of N-(2-carboxy-thieno(2,3-b)pyridin-3-yl)-amidines by the reaction with 4-oxo-4H-pyrido(3',2':4,5)-thieno(3,2-d)-1,3-oxazines with secondary cycloaliphatic amines].
Vieweg H; Leistner S; Prantz J; Böhm N; Wagner G
Pharmazie; 1992 Nov; 47(11):841-5. PubMed ID: 1492113
[TBL] [Abstract][Full Text] [Related]
34. Structure-based design and synthesis of macrocyclic human rhinovirus 3C protease inhibitors.
Namoto K; Sirockin F; Sellner H; Wiesmann C; Villard F; Moreau RJ; Valeur E; Paulding SC; Schleeger S; Schipp K; Loup J; Andrews L; Swale R; Robinson M; Farady CJ
Bioorg Med Chem Lett; 2018 Mar; 28(5):906-909. PubMed ID: 29433930
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and antiviral activity of an imidazo[1,2-a]pyrrolo[2,3-c]pyridine series against the bovine viral diarrhea virus.
Chezal JM; Paeshuyse J; Gaumet V; Canitrot D; Maisonial A; Lartigue C; Gueiffier A; Moreau E; Teulade JC; Chavignon O; Neyts J
Eur J Med Chem; 2010 May; 45(5):2044-7. PubMed ID: 20149501
[TBL] [Abstract][Full Text] [Related]
36. Antiviral 2,5-disubstituted imidazo[4,5-c]pyridines: from anti-pestivirus to anti-hepatitis C virus activity.
Puerstinger G; Paeshuyse J; De Clercq E; Neyts J
Bioorg Med Chem Lett; 2007 Jan; 17(2):390-3. PubMed ID: 17084081
[TBL] [Abstract][Full Text] [Related]
37. An orally bioavailable oxime ether capsid binder with potent activity against human rhinovirus.
Watson KG; Brown RN; Cameron R; Chalmers DK; Hamilton S; Jin B; Krippner GY; Luttick A; McConnell DB; Reece PA; Ryan J; Stanislawski PC; Tucker SP; Wu WY; Barnard DL; Sidwell RW
J Med Chem; 2003 Jul; 46(15):3181-4. PubMed ID: 12852746
[TBL] [Abstract][Full Text] [Related]
38. (S)-(-)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine maleate (SIB-1508Y): a novel anti-parkinsonian agent with selectivity for neuronal nicotinic acetylcholine receptors.
Cosford ND; Bleicher L; Herbaut A; McCallum JS; Vernier JM; Dawson H; Whitten JP; Adams P; Chavez-Noriega L; Correa LD; Crona JH; Mahaffy LS; Menzaghi F; Rao TS; Reid R; Sacaan AI; Santori E; Stauderman KA; Whelan K; Lloyd GK; McDonald IA
J Med Chem; 1996 Aug; 39(17):3235-7. PubMed ID: 8765504
[No Abstract] [Full Text] [Related]
39. Design, synthesis and biological evaluation of novel aminothiazoles as antiviral compounds acting against human rhinovirus.
Décor A; Grand-Maître C; Hucke O; O'Meara J; Kuhn C; Constantineau-Forget L; Brochu C; Malenfant E; Bertrand-Laperle M; Bordeleau J; Ghiro E; Pesant M; Fazal G; Gorys V; Little M; Boucher C; Bordeleau S; Turcotte P; Guo T; Garneau M; Spickler C; Gauthier A
Bioorg Med Chem Lett; 2013 Jul; 23(13):3841-7. PubMed ID: 23726345
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and copper-dependent antimycoplasmal activity of 1-amino-3-(2-pyridyl)isoquinoline derivatives. 1. Amides.
de Zwart MA; van der Goot H; Timmerman H
J Med Chem; 1988 Apr; 31(4):716-22. PubMed ID: 3351847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
